Literature DB >> 1714064

Pertussis toxin-sensitive G-protein mediates galanin's inhibition of scopolamine-evoked acetylcholine release in vivo and carbachol-stimulated phosphoinositide turnover in rat ventral hippocampus.

S Consolo1, R Bertorelli, P Girotti, C La Porta, T Bartfai, M Parenti, M Zambelli.   

Abstract

The effects of intracerebroventricular (i.c.v.) injections of pertussis toxin were investigated on the inhibitory action of galanin on acetylcholine release and phosphoinositide breakdown stimulated by muscarinic agents in rat ventral hippocampus. Pertussis toxin (0.6 micrograms, i.c.v., 96 h) counteracted the in vitro inhibitory effect of galanin (3.1 nmol) on phosphoinositide breakdown stimulated by carbachol without altering the stimulatory action of the cholinergic agonist on signal transduction, in miniprisms from rat ventral hippocampus. Pertussis toxin also abolished the in vivo effect of galanin on scopolamine-stimulated acetylcholine release in vivo but did not affect basal acetylcholine release. The results indicate that pertussis toxin-sensitive G-protein(s) mediates the galanin receptor regulation of pre- and postsynaptic cholinergic functions in the ventral hippocampus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1714064     DOI: 10.1016/0304-3940(91)90363-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Fronto-temporal galanin modulates impulse control.

Authors:  F Messanvi; A Perkins; J du Hoffmann; Y Chudasama
Journal:  Psychopharmacology (Berl)       Date:  2019-11-08       Impact factor: 4.530

Review 2.  Galanin--a neuropeptide with inhibitory actions.

Authors:  K Kask; U Langel; T Bartfai
Journal:  Cell Mol Neurobiol       Date:  1995-12       Impact factor: 5.046

Review 3.  Galanin-acetylcholine interactions in rodent memory tasks and Alzheimer's disease.

Authors:  M P McDonald; J N Crawley
Journal:  J Psychiatry Neurosci       Date:  1997-11       Impact factor: 6.186

4.  Patterns of seizures, hippocampal injury and neurogenesis in three models of status epilepticus in galanin receptor type 1 (GalR1) knockout mice.

Authors:  A Mazarati; X Lu; S Shinmei; H Badie-Mahdavi; T Bartfai
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

5.  Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes.

Authors:  T Bartfai; U Langel; K Bedecs; S Andell; T Land; S Gregersen; B Ahrén; P Girotti; S Consolo; R Corwin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

Review 6.  Galanin impairs cognitive abilities in rodents: relevance to Alzheimer's disease.

Authors:  J N Crawley
Journal:  Cell Mol Life Sci       Date:  2008-06       Impact factor: 9.261

7.  Coadministration of galanin antagonist M40 with a muscarinic M1 agonist improves delayed nonmatching to position choice accuracy in rats with cholinergic lesions.

Authors:  M P McDonald; L B Willard; G L Wenk; J N Crawley
Journal:  J Neurosci       Date:  1998-07-01       Impact factor: 6.167

8.  Improvement by dynorphin A (1-13) of galanin-induced impairment of memory accompanied by blockade of reductions in acetylcholine release in rats.

Authors:  M Hiramatsu; H Mori; H Murasawa; T Kameyama
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.